Abstract
Islet cell dysfunction in type 2 diabetes is primarily attributed to increased apoptosis of pancreatic β-Cells. The aim of the present study was to investigate the effects of Schisandrae chinensis oil on pancreatic β-Cells in type 2 diabetes mellitus rats and the associated molecular mechanisms of action. Wistar rats were randomly divided into diabetic rats and control rats, diabetic rats treated with Schisandrae chinensis oil (1 mg/kg), and control rats treated with Schisandrae chinensis oil. The serum fasting blood glucose, insulin, total cholesterol, and triglyceride levels along with MDA content, SOD and CAT activities in pancreatic tissues were measured. TUNEL was used to observe the apoptosis of rat pancreatic cells. Western blot was used to determine specific protein expression. The results showed that the oil significantly decreased fasting blood glucose, total cholesterol, triglyceride levels as well as the pancreatic MDA, but increased SOD and CAT activities. The protein expression of Bcl-2, PDX-1, GLUT-2, and GCK but not caspase 3 was significantly enhanced in the oil-treated rats compared with diabetic rats. However, Bax content was not significantly different between the control and DM groups. Schisandra chinensis oil improves pancreatic β-cell function by enhancing antioxidant potential of the pancreas, upregulating the expression of anti-apoptotic genes, increasing expression of glucose metabolism, and delaying islet cell apoptosis.
Similar content being viewed by others
References
H. Sone, Y. Kagawa, Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48(1), 58–67 (2005). doi:10.1007/s00125-004-1605-2
P. Marchetti, M. Bugliani, U. Boggi, M. Masini, L. Marselli, The pancreatic beta cells in human type 2 diabetes. Adv. Exp. Med. Biol. 771, 288–309 (2012)
B. Thorens, The required beta cell research for improving treatment of type 2 diabetes. J. Intern. Med. 274(3), 203–214 (2013). doi:10.1111/joim.12096
M.O. Larsen, Beta-cell function and mass in type 2 diabetes. Dan. Med. Bull. 56(3), 153–164 (2009)
C.P. Commission, China Pharmacopoeia. In vol. 1. (Chemical Industry Press, Beijing 2010), pp. 61–62
A. Panossian, G. Wikman, Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J. Ethnopharmacol. 118(2), 183–212 (2008). doi:10.1016/j.jep.2008.04.020
D.Y. Kwon, S. da Kim, H.J. Yang, S. Park, The lignan-rich fractions of Fructus Schisandrae improve insulin sensitivity via the PPAR-gamma pathways in in vitro and in vivo studies. J. Ethnopharmacol. 135(2), 455–462 (2011). doi:10.1016/j.jep.2011.03.037
C. Wang, J. Li, X. Lv, M. Zhang, Y. Song, L. Chen, Y. Liu, Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin. Eur. J. Pharmacol. 620(1–3), 131–137 (2009). doi:10.1016/j.ejphar.2009.07.027
A. Zywert, K. Szkudelska, T. Szkudelski, Inhibition of phosphodiesterase 3B in insulin-secreting cells of normal and streptozocin-nicotinamide-induced diabetic rats implications for insulin secretion. J. Physiol. Pharmacol. 65(3), 425–433 (2014)
W. Xie, L. Du, Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes. Metab. 13(4), 289–301 (2011). doi:10.1111/j.1463-1326.2010.01336.x
K.F. Cai, Z.C. Qin, Y.L. Wang, Effects of Fructus Schisandrae oil on islet cell morphology and function of diabetic mice. Chin. J. Tradit. Med. Sci. Technol. 14(3), 177–178 (2007)
K.F. Cai, Z.C. Qin, Y.L. Wang, Effects of Fructus Schisandrae oil on antioxidant and the expression of glucose transporter protein 4 mRNA of diabetic mice. Chin. Arch. Tradit. Chin. Med. 24(7), 1199–1200 (2006)
L.P. An, Y.P. Wang, X.M. Liu, Effect of Fructus Schisandrae oil on blood glucose of type 2 diabetic rats induced by Streptozotocin. Chin. Tradit. Herb. Drugs 43(3), 52–556 (2012)
J.H. Yki, Pathogenesis of noninsulin dependent diabetes mellitus. Lancet 343(8889), 91–95 (1994)
W.H. Kim, J.W. Lee, Y.H. Suh, S.H. Hong, J.S. Choi, J.H. Lim, J.H. Song, B. Gao, M.H. Jung, Exposure to chronic high glucose induces beta-cell apoptosis through decreased interaction of glucokinase with mitochondria: downregulation of glucokinase in pancreatic beta-cells. Diabetes 54(9), 2602–2611 (2005)
M. Bensellam, D.R. Laybutt, J.C. Jonas, The molecular mechanisms of pancreatic beta-cell glucotoxicity: recent findings and future research directions. Mol. Cell. Endocrinol. 364(1–2), 1–27 (2012). doi:10.1016/j.mce.2012.08.003
T. van de Weijer, V.B. Schrauwen-Hinderling, P. Schrauwen, Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc. Res. 92(1), 10–18 (2011). doi:10.1093/cvr/cvr212
J.R. Zierath, A. Krook, H. Wallberg-Henriksson, Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43(7), 821–835 (2000). doi:10.1007/s001250051457
U.K. Prospective Diabetes Study Group, U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 44(11), 1249–1258 (1995)
G.C. Weir, D.R. Laybutt, H. Kaneto, S. Bonner-Weir, A. Sharma, Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 50(Suppl 1), S154–S159 (2001)
J.D. Johnson, N.T. Ahmed, D.S. Luciani, Z. Han, H. Tran, J. Fujita, S. Misler, H. Edlund, K.S. Polonsky, Increased islet apoptosis in Pdx1 ± mice. J. Clin. Investig. 111(8), 1147–1160 (2003). doi:10.1172/JCI16537
W. Kim, J.M. Egan, The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol. Rev. 60(4), 470–512 (2008). doi:10.1124/pr.108.000604
F. Al-Quobaili, M. Montenarh, Pancreatic duodenal homeobox factor-1 and diabetes mellitus type 2 (review). Int. J. Mol. Med. 21(4), 399–404 (2008)
R. Singh, E.R. Pearson, P.M. Clark, A.T. Hattersley, The long-term impact on offspring of exposure to hyperglycaemia in utero due to maternal glucokinase gene mutations. Diabetologia 50(3), 620–624 (2007). doi:10.1007/s00125-006-0541-8
R.N. Kulkarni, U.S. Jhala, J.N. Winnay, S. Krajewski, M. Montminy, C.R. Kahn, PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J. Clin. Investig. 114(6), 828–836 (2004). doi:10.1172/JCI21845
H. Kaneto, T. Miyatsuka, D. Kawamori, T.A. Matsuoka, Pleiotropic roles of PDX-1 in the pancreas. Rev. Diabet. Stud. 4(4), 209–225 (2007). doi:10.1900/RDS.2007.4.209
H. Kaneto, T. Miyatsuka, T. Shiraiwa, K. Yamamoto, K. Kato, Y. Fujitani, T.A. Matsuoka, Crucial role of PDX-1 in pancreas development, beta-cell differentiation, and induction of surrogate beta-cells. Curr. Med. Chem. 14(16), 1745–1752 (2007)
Acknowledgments
This work was funded by project “2013-199” supported by the Education Department of Jilin Province, project “201262503” supported by Sci-tech Department of Jilin City and project “20122082” the Healthe Department of Jilin Province.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
An, L., Wang, Y., Wang, C. et al. Protective effect of Schisandrae chinensis oil on pancreatic β-cells in diabetic rats. Endocrine 48, 818–825 (2015). https://doi.org/10.1007/s12020-014-0375-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-014-0375-y